Our results are consistent with studies performed by Chuaysri C14 and Okabe H,30 which also indicated that α‐SMA expression in fibroblasts may be a predictor of poor prognosis in cholangiocarcinoma. This evidence concerns the gene ACTA1 and cholangiocarcinoma.